Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient.

Castellazzi M, Morotti A, Tamborino C, Alessi F, Pilotto S, Baldi E, Caniatti LM, Trentini A, Casetta I, Granieri E, Pugliatti M, Fainardi E, Bellini T.

Fluids Barriers CNS. 2020 Feb 5;17(1):14. doi: 10.1186/s12987-020-0173-2.

2.

Specific antibodies reacting to JC polyomavirus capsid protein mimotopes in sera from multiple sclerosis and other neurological diseases-affected patients.

Mazzoni E, Bononi I, Pietrobon S, Torreggiani E, Rossini M, Pugliatti M, Casetta I, Castellazzi M, Granieri E, Guerra G, Martini F, Tognon M.

J Cell Physiol. 2020 Feb 3. doi: 10.1002/jcp.29533. [Epub ahead of print]

PMID:
32012272
3.

Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer's disease and mild cognitive impairment.

Castellazzi M, Patergnani S, Donadio M, Giorgi C, Bonora M, Bosi C, Brombo G, Pugliatti M, Seripa D, Zuliani G, Pinton P.

Sci Rep. 2019 Dec 27;9(1):20009. doi: 10.1038/s41598-019-56614-5.

4.

Henoch-Schönlein Purpura in children: not only kidney but also lung.

Di Pietro GM, Castellazzi ML, Mastrangelo A, Montini G, Marchisio P, Tagliabue C.

Pediatr Rheumatol Online J. 2019 Nov 21;17(1):75. doi: 10.1186/s12969-019-0381-y. Review.

5.

Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study.

Fainardi E, Bortolotti D, Castellazzi M, Casetta I, Bellini T, Rizzo R.

Hum Immunol. 2019 Nov 14. pii: S0198-8859(19)31015-8. doi: 10.1016/j.humimm.2019.11.004. [Epub ahead of print]

PMID:
31735441
6.

Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients.

Castellazzi M, Lamberti G, Resi MV, Baldi E, Caniatti LM, Galante G, Perri P, Pugliatti M.

Dis Markers. 2019 Sep 10;2019:9320791. doi: 10.1155/2019/9320791. eCollection 2019.

7.

Otogenic temporomandibular septic arthritis in a child: a case report and a review of the literature.

Castellazzi ML, Senatore L, Di Pietro G, Pinzani R, Torretta S, Coro I, Russillo A, Borzani I, Bosis S, Marchisio P.

Ital J Pediatr. 2019 Jul 22;45(1):88. doi: 10.1186/s13052-019-0682-2. Review.

8.

Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients.

Castellazzi M, Patergnani S, Donadio M, Giorgi C, Bonora M, Fainardi E, Casetta I, Granieri E, Pugliatti M, Pinton P.

J Neuroinflammation. 2019 Jun 27;16(1):131. doi: 10.1186/s12974-019-1526-0.

9.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C.

Mult Scler. 2019 May 8:1352458519845844. doi: 10.1177/1352458519845844. [Epub ahead of print]

PMID:
31066634
10.

Benzodiazepines versus placebo for panic disorder in adults.

Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJ, Furukawa TA, Koesters M.

Cochrane Database Syst Rev. 2019 Mar 28;3:CD010677. doi: 10.1002/14651858.CD010677.pub2.

PMID:
30921478
11.

Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients.

Castellazzi M, Ligi D, Contaldi E, Quartana D, Fonderico M, Borgatti L, Bellini T, Trentini A, Granieri E, Fainardi E, Mannello F, Pugliatti M.

Front Neurol. 2018 Dec 18;9:1080. doi: 10.3389/fneur.2018.01080. eCollection 2018.

12.

Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up.

Granieri E, Andreasi NG, De Martin P, Govoni V, Castellazzi M, Cesnik E, Pugliatti M, Casetta I.

Neurol Sci. 2019 Mar;40(3):603-609. doi: 10.1007/s10072-018-3688-4. Epub 2019 Jan 7.

PMID:
30617450
13.

Listeria monocytogenes meningitis in immunocompetent and healthy children: a case report and a review of the literature.

Castellazzi ML, Marchisio P, Bosis S.

Ital J Pediatr. 2018 Dec 29;44(1):152. doi: 10.1186/s13052-018-0595-5. Review.

14.

Multiple Sclerosis in Italy: A 40-Year Follow-Up of the Prevalence in Ferrara.

Granieri E, De Mattia G, Laudisi M, Govoni V, Castellazzi M, Caniatti L, Baldi E, Groppo E, Pugliatti M, Casetta I.

Neuroepidemiology. 2018;51(3-4):158-165. doi: 10.1159/000491548. Epub 2018 Aug 21.

PMID:
30130759
15.

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis.

Castellazzi ML, Esposito S, Claut LE, Daccò V, Colombo C.

Ital J Pediatr. 2018 Aug 15;44(1):93. doi: 10.1186/s13052-018-0535-4.

16.

Antidepressants versus placebo for panic disorder in adults.

Bighelli I, Castellazzi M, Cipriani A, Girlanda F, Guaiana G, Koesters M, Turrini G, Furukawa TA, Barbui C.

Cochrane Database Syst Rev. 2018 Apr 5;4:CD010676. doi: 10.1002/14651858.CD010676.pub2. Review.

17.

Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature.

Meid AD, Bighelli I, Mächler S, Mikus G, Carrà G, Castellazzi M, Lucii C, Martinotti G, Nosè M, Ostuzzi G, Barbui C, Haefeli WE.

Ther Adv Psychopharmacol. 2017 Dec;7(12):251-264. doi: 10.1177/2045125317721662. Epub 2017 Aug 28.

18.

Cerebrospinal fluid analysis and the determination of oligoclonal bands.

Gastaldi M, Zardini E, Leante R, Ruggieri M, Costa G, Cocco E, De Luca G, Cataldo I, Biagioli T, Ballerini C, Castellazzi M, Fainardi E, Pettini P, Zaffaroni M, Giunti D, Capello E, Bernardi G, Ciusani E, Giannotta C, Nobile-Orazio E, Bazzigaluppi E, Passerini G, Bedin R, Sola P, Brivio R, Cavaletti G, Sala A, Bertolotto A, Desina G, Leone MA, Mariotto S, Ferrari S, Paternoster A, Giavarina D, Lolli F, Franciotta D.

Neurol Sci. 2017 Oct;38(Suppl 2):217-224. doi: 10.1007/s10072-017-3034-2. Review.

PMID:
29030765
19.

Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals.

Patergnani S, Castellazzi M, Bonora M, Marchi S, Casetta I, Pugliatti M, Giorgi C, Granieri E, Pinton P.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):439-441. doi: 10.1136/jnnp-2017-316234. Epub 2017 Sep 2. No abstract available.

PMID:
28866627
20.

Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.

Trentini A, Castellazzi M, Romani A, Squerzanti M, Baldi E, Caniatti ML, Pugliatti M, Granieri E, Fainardi E, Bellini T, Cervellati C.

J Neurol Sci. 2017 Jun 15;377:133-136. doi: 10.1016/j.jns.2017.04.021. Epub 2017 Apr 13.

PMID:
28477683
21.

Matrix Metalloproteinases as a Pleiotropic Biomarker in Medicine and Biology.

Kurzepa J, El-Demerdash FM, Castellazzi M.

Dis Markers. 2016;2016:9275204. Epub 2016 Nov 9. No abstract available.

22.

Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.

Nosè M, Bighelli I, Castellazzi M, Martinotti G, Carrà G, Lucii C, Ostuzzi G, Sozzi F, Barbui C; STAR NETWORK GROUP.

Epidemiol Psychiatr Sci. 2016 Dec;25(6):532-540. Epub 2015 Oct 15.

PMID:
26467074
23.

Antidepressants and benzodiazepines for panic disorder in adults.

Bighelli I, Trespidi C, Castellazzi M, Cipriani A, Furukawa TA, Girlanda F, Guaiana G, Koesters M, Barbui C.

Cochrane Database Syst Rev. 2016 Sep 12;9:CD011567. doi: 10.1002/14651858.CD011567.pub2. Review.

24.

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.

Trentini A, Castellazzi M, Cervellati C, Manfrinato MC, Tamborino C, Hanau S, Volta CA, Baldi E, Kostic V, Drulovic J, Granieri E, Dallocchio F, Bellini T, Dujmovic I, Fainardi E.

Dis Markers. 2016;2016:3672353. doi: 10.1155/2016/3672353. Epub 2016 Jul 31.

25.

Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis.

Rizzo R, Pietrobon S, Mazzoni E, Bortolotti D, Martini F, Castellazzi M, Casetta I, Fainardi E, Di Luca D, Granieri E, Tognon M; Emilia-Romagna network for Multiple Sclerosis (ERMES) study group.

J Transl Med. 2016 Jul 22;14(1):216. doi: 10.1186/s12967-016-0981-y.

26.

Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.

Castellazzi M, Bellini T, Trentini A, Delbue S, Elia F, Gastaldi M, Franciotta D, Bergamaschi R, Manfrinato MC, Volta CA, Granieri E, Fainardi E.

Dis Markers. 2016;2016:8434209. doi: 10.1155/2016/8434209. Epub 2016 Jun 2.

27.

Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.

Castellazzi M, Trentini A, Romani A, Valacchi G, Bellini T, Bonaccorsi G, Fainardi E, Cavicchio C, Passaro A, Zuliani G, Cervellati C.

Int J Biochem Cell Biol. 2016 Dec;81(Pt B):356-363. doi: 10.1016/j.biocel.2016.06.008. Epub 2016 Jun 14.

PMID:
27312742
28.

First-generation antipsychotics and QTc: any role for mediating variables?

Carrà G, Crocamo C, Bartoli F, Lax A, Tremolada M, Lucii C, Martinotti G, Nosè M, Bighelli I, Ostuzzi G, Castellazzi M, Clerici M, Barbui C; STAR Network Group.

Hum Psychopharmacol. 2016 Jul;31(4):313-8. doi: 10.1002/hup.2540. Epub 2016 Jun 1.

PMID:
27245736
29.

Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.

Doronin VB, Parkhomenko TA, Castellazzi M, Cesnik E, Buneva VN, Granieri E, Nevinsky GA.

PLoS One. 2016 May 19;11(5):e0154688. doi: 10.1371/journal.pone.0154688. eCollection 2016.

30.

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.

Barbui C, Bighelli I, Carrà G, Castellazzi M, Lucii C, Martinotti G, Nosè M, Ostuzzi G; STAR NETWORK INVESTIGATORS.

PLoS One. 2016 Feb 3;11(2):e0148212. doi: 10.1371/journal.pone.0148212. eCollection 2016.

31.

Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.

Castellazzi M, Delbue S, Elia F, Gastaldi M, Franciotta D, Rizzo R, Bellini T, Bergamaschi R, Granieri E, Fainardi E.

Dis Markers. 2015;2015:901312. doi: 10.1155/2015/901312. Epub 2015 May 26.

32.

Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis.

Fainardi E, Bortolotti D, Bolzani S, Castellazzi M, Tamborino C, Roversi G, Baldi E, Caniatti ML, Casetta I, Gentili V, Granieri E, Rizzo R; ERMES study group.

Mult Scler. 2016 Feb;22(2):245-9. doi: 10.1177/1352458515590647. Epub 2015 Jun 17.

PMID:
26084349
33.

TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis.

Trentini A, Manfrinato MC, Castellazzi M, Tamborino C, Roversi G, Volta CA, Baldi E, Tola MR, Granieri E, Dallocchio F, Bellini T, Fainardi E; Emilia-Romagna network for Multiple Sclerosis (ERMES) study group.

Mult Scler. 2015 Aug;21(9):1121-30. doi: 10.1177/1352458514560925. Epub 2015 Feb 6.

PMID:
25662349
34.

Serum ferroxidase activity in patients with multiple sclerosis: a pilot study.

Cervellati C, Romani A, Fainardi E, Trentini A, Squerzanti M, Baldi E, Caniatti ML, Granieri E, Bellini T, Castellazzi M.

In Vivo. 2014 Nov-Dec;28(6):1197-200.

PMID:
25398823
35.

Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.

Castellazzi M, Contini C, Tamborino C, Fasolo F, Roversi G, Seraceni S, Rizzo R, Baldi E, Tola MR, Bellini T, Granieri E, Fainardi E.

J Neuroinflammation. 2014 Nov 13;11:188. doi: 10.1186/s12974-014-0188-1.

36.

Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis.

Mazzoni E, Pietrobon S, Masini I, Rotondo JC, Gentile M, Fainardi E, Casetta I, Castellazzi M, Granieri E, Caniati ML, Tola MR, Guerra G, Martini F, Tognon M.

PLoS One. 2014 Nov 3;9(11):e110923. doi: 10.1371/journal.pone.0110923. eCollection 2014.

37.

Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial.

Girlanda F, Cipriani A, Agrimi E, Appino MG, Barichello A, Beneduce R, Bighelli I, Bisoffi G, Bisogno A, Bortolaso P, Boso M, Calandra C, Cascone L, Castellazzi M, Corbascio C, Parise VF, Gardellin F, Gennaro D, Hanife B, Lintas C, Lorusso M, Luca A, Luca M, Luchetta C, Lucii C, Maio F, Marsilio A, Mattei C, Moretti D, Nosè M, Occhionero G, Papanti D, Pecile D, Percudani M, Prestia D, Purgato M, Restaino F, Romeo S, Sciarma T, Strizzolo S, Tamborini S, Todarello O, Tozzi F, Ziero S, Zotos S, Barbui C.

BMC Res Notes. 2014 Oct 17;7:731. doi: 10.1186/1756-0500-7-731.

38.

Azapirones versus placebo for panic disorder in adults.

Imai H, Tajika A, Chen P, Pompoli A, Guaiana G, Castellazzi M, Bighelli I, Girlanda F, Barbui C, Koesters M, Cipriani A, Furukawa TA.

Cochrane Database Syst Rev. 2014 Sep 30;(9):CD010828. doi: 10.1002/14651858.CD010828.pub2. Review.

PMID:
25268297
39.

Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Doronin VB, Parkhomenko TA, Castellazzi M, Padroni M, Pastore M, Buneva VN, Granieri E, Nevinsky GA.

PLoS One. 2014 Sep 29;9(9):e107807. doi: 10.1371/journal.pone.0107807. eCollection 2014.

40.

Changes in climate variability with reference to land quality and agriculture in Scotland.

Brown I, Castellazzi M.

Int J Biometeorol. 2015 Jun;59(6):717-32. doi: 10.1007/s00484-014-0882-9. Epub 2014 Aug 7.

PMID:
25099211
41.

Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Parkhomenko TA, Doronin VB, Castellazzi M, Padroni M, Pastore M, Buneva VN, Granieri E, Nevinsky GA.

PLoS One. 2014 Apr 15;9(4):e93001. doi: 10.1371/journal.pone.0093001. eCollection 2014.

42.

Episodic idiopathic systemic capillary leak syndrome in a girl.

Milani GP, Dellepiane RM, Castellazzi ML, Mazzoni MB, Bianchetti MG, Fossali EF.

Pediatr Int. 2013 Aug;55(4):e81-2. doi: 10.1111/ped.12068.

PMID:
23910812
43.

Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.

Rizzo R, Trentini A, Bortolotti D, Manfrinato MC, Rotola A, Castellazzi M, Melchiorri L, Di Luca D, Dallocchio F, Fainardi E, Bellini T.

Mol Cell Biochem. 2013 Sep;381(1-2):243-55. doi: 10.1007/s11010-013-1708-5. Epub 2013 Jun 5.

PMID:
23737137
44.

Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation.

Morandi F, Venturi C, Rizzo R, Castellazzi M, Baldi E, Caniatti ML, Tola MR, Granieri E, Fainardi E, Uccelli A, Pistoia V.

J Neuroimmune Pharmacol. 2013 Sep;8(4):944-55. doi: 10.1007/s11481-013-9459-3. Epub 2013 Apr 28.

PMID:
23625177
45.

The interactive responses of water quality and hydrology to changes in multiple stressors, and implications for the long-term effective management of phosphorus.

Crossman J, Whitehead PG, Futter MN, Jin L, Shahgedanova M, Castellazzi M, Wade AJ.

Sci Total Environ. 2013 Jun 1;454-455:230-44. doi: 10.1016/j.scitotenv.2013.02.033. Epub 2013 Mar 29.

PMID:
23542675
46.

Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker.

Antonelli T, Tomasini MC, Castellazzi M, Sola P, Tamborino C, Ferraro D, Ferraro L, Granieri E.

Neurol Sci. 2013 May;34(5):769-71. doi: 10.1007/s10072-012-1265-9. Epub 2012 Dec 18.

PMID:
23247598
47.

Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.

Rizzo R, Bortolotti D, Fredj NB, Rotola A, Cura F, Castellazzi M, Tamborino C, Seraceni S, Baldi E, Melchiorri L, Tola MR, Granieri E, Baricordi OR, Fainardi E.

Hum Immunol. 2012 Nov;73(11):1140-6. doi: 10.1016/j.humimm.2012.08.005. Epub 2012 Aug 22.

PMID:
22922127
48.

Integrating economic and biophysical data in assessing cost-effectiveness of buffer strip placement.

Balana BB, Lago M, Baggaley N, Castellazzi M, Sample J, Stutter M, Slee B, Vinten A.

J Environ Qual. 2012 Mar-Apr;41(2):380-8. doi: 10.2134/jeq2010.0544.

PMID:
22370400
49.

Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms.

Bellini T, Trentini A, Manfrinato MC, Tamborino C, Volta CA, Di Foggia V, Fainardi E, Dallocchio F, Castellazzi M.

J Biochem. 2012 May;151(5):493-9. doi: 10.1093/jb/mvs014. Epub 2012 Feb 17.

PMID:
22343748
50.

Intrathecal levels of vitamin D and IgG in multiple sclerosis.

Holmøy T, Lossius A, Gundersen TE, Moen SM, Castellazzi M, Fainardi E, Casetta I.

Acta Neurol Scand. 2012 Jun;125(6):e28-31. doi: 10.1111/j.1600-0404.2011.01577.x. Epub 2011 Jul 23.

PMID:
21781056

Supplemental Content

Loading ...
Support Center